Literature DB >> 22044578

Immunomodulatory properties of Xylaria nigripes in peritoneal macrophage cells of Balb/c mice.

Huey-Jiun Ko1, Airong Song, Min-Nan Lai, Lean-Teik Ng.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Wu Ling Shen, a folklore name for Xylaria nigripes (XN), is a high value medicinal fungus used in traditional Chinese medicine.
AIM OF STUDY: The present study aimed to examine the immunomodulatory properties of aqueous (XN-H) and ethanol (XN-E) XN extracts in lipopolysaccharide (LPS)-induced peritoneal macrophage cells of Balb/c mice.
MATERIALS AND METHODS: After treating the macrophage cells with LPS (1 μg/ml) and different XN extracts, the immunomodulatory properties were determined by the responses of inflammatory mediators, namely nitrite oxide (NO), prostaglandin E2 (PGE(2)) and cytokine (IL-1β, IL-6, TNF-α and IFN-γ) production, iNOS, COX-2 and IκB-α expression, and NF-κB activation.
RESULTS: Results showed that treatment of macrophages with 5-30 μg/ml of XN-H or XN-E plus 1 μg/ml LPS exhibited no cytotoxic effect on cell viability. At these concentrations, although both XN-H and XN-E showed a dose-dependent inhibitory effect on NO, PGE(2), IL-1β, IL-6, TNF-α and IFN-γ production in LPS-stimulated macrophages, a greater potency was noted in the XN-H treated group. RT-PCR assay also showed that XN-H possessed a greater inhibition than XN-E on iNOS and COX-2 RNA expression. Furthermore, XN-H also showed a significant stronger suppression than XN-E on the LPS-induced IκB-α phosphorylation and NF-κB activation. XN-E showed a higher total flavonoid and phenol contents but a lower β-glucan content than XN-H.
CONCLUSION: Taken together, these results conclude that XN-H possesses a stronger anti-inflammatory activity than XN-E, and its mechanism of action could be mediated by inhibiting iNOS and COX-2 expression via the NF-κB signaling pathway, and these activities could be contributed by the β-glucan content.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044578     DOI: 10.1016/j.jep.2011.10.022

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Xylaria nigripes mitigates spatial memory impairment induced by rapid eye movement sleep deprivation.

Authors:  Zhengqing Zhao; Yanpeng Li; Haiyan Chen; Liuqing Huang; Fei Zhao; Qiang Yu; Zhenghua Xiang; Zhongxin Zhao
Journal:  Int J Clin Exp Med       Date:  2014-02-15

Review 2.  Spirocyclic derivatives as antioxidants: a review.

Authors:  Karen Acosta-Quiroga; Cristian Rojas-Peña; Luz Stella Nerio; Margarita Gutiérrez; Efraín Polo-Cuadrado
Journal:  RSC Adv       Date:  2021-06-21       Impact factor: 4.036

3.  Protective effect of medicinal fungus Xylaria nigripes mycelia extracts against hydrogen peroxide-induced apoptosis in PC12 cells.

Authors:  Rupesh D Divate; Pei-Ming Wang; Chiun-Chuang Wang; Su-Tze Chou; Chen-Tien Chang; Yun-Chin Chung
Journal:  Int J Immunopathol Pharmacol       Date:  2017-02-01       Impact factor: 3.219

4.  Actin cytoskeletal inhibitor 19,20-epoxycytochalasin Q sensitizes yeast cells lacking ERG6 through actin-targeting and secondarily through disruption of lipid homeostasis.

Authors:  Kwanrutai Watchaputi; Pichayada Somboon; Nipatthra Phromma-In; Khanok Ratanakhanokchai; Nitnipa Soontorngun
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

5.  Evaluation of cytotoxic and anti-inflammatory activities of extracts and lectins from Moringa oleifera seeds.

Authors:  Larissa Cardoso Corrêa Araújo; Jaciana Santos Aguiar; Thiago Henrique Napoleão; Fernanda Virgínia Barreto Mota; André Luiz Souza Barros; Maiara Celine Moura; Marília Cavalcanti Coriolano; Luana Cassandra Breitenbach Barroso Coelho; Teresinha Gonçalves Silva; Patrícia Maria Guedes Paiva
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

Review 6.  Immunomodulatory Effects of Edible and Medicinal Mushrooms and Their Bioactive Immunoregulatory Products.

Authors:  Shuang Zhao; Qi Gao; Chengbo Rong; Shouxian Wang; Zhekun Zhao; Yu Liu; Jianping Xu
Journal:  J Fungi (Basel)       Date:  2020-11-08

Review 7.  The Management and Alternative Therapies for Comorbid Sleep Disorders in Epilepsy.

Authors:  Weifeng Peng; Jing Ding; Xin Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.